Parabilis Medicines, Inc.
PBLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657677
In the last 90 days, Parabilis Medicines, Inc. insiders filed 2 open-market purchases and 0 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $2.71B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Parabilis Medicines, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 79
- +79 vs. Q1 2026
- Shares held
- 99.0M
- +99.0M vs. Q1 2026
- Total value
- $2.71B
- +$2.71B vs. Q1 2026
- New holders
- 79
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $2.71B |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Parabilis Medicines, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bogart Wealth, LLC | 19 | $520 | 0.00% | +19 | New |
| Cornerstone Financial Management LLC | 29 | $794 | 0.00% | +29 | New |
| Avion Wealth | 69 | $1.00K | 0.00% | +69 | New |
| North Star Investment Management Corp. | 52 | $1.42K | 0.00% | +52 | New |
| UMA Financial Services, Inc. | 59 | $1.61K | 0.00% | +59 | New |
| Fifth Third Bancorp | 60 | $1.64K | 0.00% | +60 | New |
| Allworth Financial LP | 100 | $2.74K | 0.00% | +100 | New |
| Jones Financial Companies LLLP | 103 | $2.97K | 0.00% | +103 | New |
| Atlantic Union Bankshares Corp | 180 | $4.93K | 0.00% | +180 | New |
| Morgan Stanley | 200 | $5.47K | 0.00% | +200 | New |
| EverSource Wealth Advisors, LLC | 261 | $7.14K | 0.00% | +261 | New |
| Bell Investment Advisors, Inc | 451 | $12.3K | 0.00% | +451 | New |
| Longaeva Partners L.P. | 500 | $13.7K | 0.00% | +500 | New |
| Rialto Wealth Management, LLC | 508 | $13.9K | 0.00% | +508 | New |
| Parallel Advisors, LLC | 550 | $15.1K | 0.00% | +550 | New |
| Advisor Group Holdings, Inc. | 920 | $25.2K | 0.00% | +920 | New |
| Wells Fargo & Company | 1,152 | $31.5K | 0.00% | +1,152 | New |
| China Universal Asset Management Co., Ltd. | 1,600 | $43.8K | 0.00% | +1,600 | New |
| Citigroup Inc | 1,869 | $51.2K | 0.00% | +1,869 | New |
| Tower Research Capital LLC (TRC) | 2,070 | $56.7K | 0.00% | +2,070 | New |
| Persistent Asset Partners Ltd | 4,130 | $113.0K | 0.04% | +4,130 | New |
| Goldman Sachs Group Inc | 8,253 | $225.9K | 0.00% | +8,253 | New |
| Two Sigma Investments, LP | 8,741 | $239.2K | 0.00% | +8,741 | New |
| Scientech Research LLC | 9,564 | $261.8K | 0.21% | +9,564 | New |
| ExodusPoint Capital Management, LP | 9,691 | $265.2K | 0.00% | +9,691 | New |
| Alyeska Investment Group, L.P. | 10,000 | $273.7K | 0.00% | +10,000 | New |
| Burkehill Global Management, LP | 10,000 | $273.7K | 0.01% | +10,000 | New |
| Seven Grand Managers, LLC | 10,000 | $273.7K | 0.01% | +10,000 | New |
| JustInvest LLC | 11,729 | $321.0K | 0.00% | +11,729 | New |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 19,200 | $525.5K | 0.00% | +19,200 | New |
| Ghisallo Capital Management LLC | 20,000 | $547.4K | 0.01% | +20,000 | New |
| Brevan Howard Capital Management LP | 22,565 | $617.6K | 0.01% | +22,565 | New |
| Hudson Bay Capital Management LP | 22,690 | $621.0K | 0.00% | +22,690 | New |
| Balyasny Asset Management LLC | 24,264 | $664.1K | 0.00% | +24,264 | New |
| Vanguard Fiduciary Trust Co | 27,800 | $760.9K | 0.00% | +27,800 | New |
| Winton Group Ltd | 34,900 | $955.2K | 0.03% | +34,900 | New |
| UBS Group AG | 38,698 | $1.06M | 0.00% | +38,698 | New |
| Tudor Investment Corp Et Al | 44,045 | $1.21M | 0.00% | +44,045 | New |
| Squarepoint Ops LLC | 48,484 | $1.33M | 0.00% | +48,484 | New |
| TD Asset Management Inc | 76,982 | $2.11M | 0.00% | +76,982 | New |
| Geode Capital Management, LLC | 99,358 | $2.72M | 0.00% | +99,358 | New |
| Driehaus Capital Management LLC | 100,000 | $2.74M | 0.02% | +100,000 | New |
| Ameriprise Financial Inc | 174,773 | $4.78M | 0.00% | +174,773 | New |
| Federated Hermes, Inc. | 246,200 | $6.74M | 0.01% | +246,200 | New |
| Kynam Capital Management, LP | 250,000 | $6.84M | 0.38% | +250,000 | New |
| Massachusetts Financial Services Co | 295,962 | $8.10M | 0.00% | +295,962 | New |
| ICONIQ Capital, LLC | 350,000 | $9.58M | 0.28% | +350,000 | New |
| Franklin Resources Inc | 381,487 | $10.4M | 0.00% | +381,487 | New |
| Marshall Wace, LLP | 445,359 | $12.2M | 0.01% | +445,359 | New |
| Baker Bros. Advisors LP | 500,000 | $13.7M | 0.07% | +500,000 | New |
| Bellevue Group AG | 500,000 | $13.7M | 0.29% | +500,000 | New |
| Logos Global Management LP | 525,000 | $14.4M | 0.62% | +525,000 | New |
| Samsara BioCapital, LLC | 556,044 | $15.2M | 1.25% | +556,044 | New |
| Rock Springs Capital Management LP | 578,028 | $15.8M | 0.77% | +578,028 | New |
| VR Adviser, LLC | 625,000 | $17.1M | 0.52% | +625,000 | New |
| Casdin Capital, LLC | 645,690 | $17.7M | 0.88% | +645,690 | New |
| Price T Rowe Associates Inc | 751,947 | $20.6M | 0.00% | +751,947 | New |
| Alliancebernstein L.P. | 810,279 | $22.2M | 0.01% | +810,279 | New |
| Catalio Capital Management, LP | 824,043 | $22.6M | 4.24% | +824,043 | New |
| Foresite Capital Management VI LLC | 999,044 | $27.3M | 4.26% | +999,044 | New |
| JPMorgan Chase & Co | 1,042,772 | $30.4M | 0.00% | +1,042,772 | New |
| Vanguard Capital Management LLC | 1,156,962 | $31.7M | 0.00% | +1,156,962 | New |
| Vanguard Portfolio Management LLC | 1,302,479 | $35.6M | 0.00% | +1,302,479 | New |
| Soleus Capital Management, L.P. | 1,465,070 | $40.1M | 1.38% | +1,465,070 | New |
| General Atlantic LLC | 1,538,461 | $42.1M | 1.45% | +1,538,461 | New |
| General Catalyst Group Management, LLC | 1,600,937 | $43.8M | 23.24% | +1,600,937 | New |
| Deerfield Management Company, L.P. (Series C) | 1,880,704 | $51.5M | 0.54% | +1,880,704 | New |
| Frazier Life Sciences Management, L.P. | 1,920,805 | $52.6M | 1.14% | +1,920,805 | New |
| Jupiter Topco LLC | 2,296,547 | $62.7M | 0.03% | +2,296,547 | New |
| Farallon Capital Management, L.L.C. | 2,368,200 | $64.8M | 0.38% | +2,368,200 | New |
| Siren, L.L.C. | 2,992,259 | $81.9M | 1.66% | +2,992,259 | New |
| Regeneron Pharmaceuticals, Inc. | 4,166,666 | $114.0M | 64.35% | +4,166,666 | New |
| Cormorant Asset Management, LP | 4,615,612 | $126.3M | 6.47% | +4,615,612 | New |
| Nextech Invest, Ltd. | 4,663,176 | $127.6M | 6.06% | +4,663,176 | New |
| Alphabet Inc. | 4,919,498 | $134.6M | 0.14% | +4,919,498 | New |
| venBio Partners LLC | 5,266,697 | $144.1M | 27.75% | +5,266,697 | New |
| ARCH Venture Management, LLC | 6,412,780 | $175.5M | 15.95% | +6,412,780 | New |
| FMR LLC | 10,292,735 | $281.7M | 0.01% | +10,292,735 | New |
| Ra Capital Management, L.P. | 28,933,371 | $791.9M | 6.88% | +28,933,371 | New |